Subscribe!
Who is John Mugarian? What is Dynamic Growth? Customer Service Contact Home
The Journal Reports Questions and Answers Newsletter Portfolio Links


« Catalyst For A Rally | Main | Recession On The Way »

A Question On Boston Scientific (BSX)

I recently received this question on Boston Scientific (BSX);

Dear John,

I bought BSX back when you noted the large insider buyer. Since than its down about $5.00/share to $16.30. What would be your thoughts at this point [ie., Hold, Sell, Buy more, etc.] I'm new to the investing/trading world and your blog and help are much appreciated.

Sorry about the 5 point decline, I was early on the stock as I was following the trail of the corporate insiders. Also, the stock was down 20 points from its 2004 high.

Basically, BSX got hit with news of a product recall associated with some implanted devices. This problem was inherited with the purchase of Guidant (GDT).

The company issued a letter addressing the problems related to the capacitors of its implanted devices. They further said they would replace the defective devices and take a 2Q charge.

There will be a lot of news about law suits related to the recall and how Guidant failed to notify physicians in a timely manor. The settlements associated with this problem will keep a lid on the stock for the next year or so. Given the magnitude of the decline in its share price, a company like JNJ or Medtronic may be willing to assume the risk of owning BSX at $25 or less.

Disclaimer—This is for informational purposes only and is in no way a solicitation or an offer to sell securities. I am a registered investment advisor, but only provide solicited advice to clients of our firm in states where we are registered or where an exemption or exclusion from such registration exists. nothing on this website should be interpreted to state or imply that past results are any indication of future performance. carefully assess your own risk tolerance and goals before investing.